Qiliqiangxin prevents right ventricular remodeling by inhibiting apoptosis and improving metabolism reprogramming with pulmonary arterial hypertension

Autor: Lu, Yingdong, Wu, Jing, Sun, Yuchan, Xin, Laiyun, Jiang, Zhilin, Lin, Hongchen, Zhao, Mingjing, Cui, Xiangning

Publikováno v: Am J Transl Res

Pathological remodeling of the right ventricular (RV) contributes to the mortality of pulmonary arterial hypertension (PAH) patients, and RV myocardial apoptosis and metabolism play decisive roles in RV remodeling. Qiliqiangxin (QLQX), a traditional

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3dbbd48eb7721257fe3f7bfa6b723c8b
https://europepmc.org/articles/PMC7540132/

Qiliqiangxin prevents right ventricular remodeling by inhibiting apoptosis and improving metabolism reprogramming with pulmonary arterial hypertension.

Autor: Lu Y; Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences Beijing, China., Wu J; Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences Beijing, China., Sun Y; Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences Beijing, China., Xin L; Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences Beijing, China., Jiang Z; Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences Beijing, China., Lin H; Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences Beijing, China., Zhao M; The Key Laboratory of Chinese Internal Medicine of The Ministry of Education, Dongzhimen Hospital, Beijing University of Chinese Medicine Beijing, China., Cui X; Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences Beijing, China.

Publikováno v: American journal of translational research [Am J Transl Res] 2020 Sep 15; Vol. 12 (9), pp. 5655-5669. Date of Electronic Publication: 2020 Sep 15 (Print Publication: 2020).